Literature DB >> 32318846

Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.

Huanjun Wang1, Xiaopan Xu2, Xi Zhang2, Yang Liu2, Longyuan Ouyang1, Peng Du2, Shurong Li1, Qiang Tian3, Jian Ling1, Yan Guo4, Hongbing Lu5.   

Abstract

OBJECTIVES: To develop a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer (BCa).
METHODS: This retrospective study involved 106 eligible patients from two independent clinical centers. All patients underwent a preoperative 3.0 T MRI scan with T2-weighted image (T2WI) and multi-b-value diffusion-weighted image (DWI) sequences. In total, 1404 radiomics features were extracted from the largest region of the reported tumor locations on the T2WI, DWI, and corresponding apparent diffusion coefficient map (ADC) of each patient. A radiomics signature, namely the Radscore, was then generated using the recursive feature elimination approach and a logistic regression algorithm in a training cohort (n = 64). Its performance was then validated in an independent validation cohort (n = 42). The primary imaging and clinical factors in conjunction with the Radscore were used to determine whether the performance could be further improved.
RESULTS: The Radscore, generated by 36 selected radiomics features, demonstrated a favorable ability to predict muscle-invasive BCa status in both the training (AUC 0.880) and validation (AUC 0.813) cohorts. Subsequently, integrating the two independent predictors (including the Radscore and MRI-determined tumor stalk) into a nomogram exhibited more favorable discriminatory performance, with the AUC improved to 0.924 and 0.877 in both cohorts, respectively.
CONCLUSIONS: The proposed multisequence MRI-based radiomics signature alone could be an effective tool for quantitative prediction of muscle-invasive status of BCa. Integrating the Radscore with MRI-determined tumor stalk could further improve the discriminatory power, realizing more accurate prediction of nonmuscle-invasive and muscle-invasive BCa. KEY POINTS: • DWI is superior to T2WI sequence in reflecting the heterogeneous differences between NMIBC and MIBC, and multisequence MRI helps in the preoperative prediction of muscle-invasive status of BCa. • Co-occurrence (CM), run-length matrix (RLM), and gray-level size zone matrix (GLSZM) features were the favorable feature categories for the prediction of muscle-invasive status of BCa. • The Radscore (proposed multisequence MRI-based radiomics signature) helps predict preoperatively muscle invasion. Combination with the MRI-determined tumor stalk further improves prediction.

Entities:  

Keywords:  Apparent diffusion coefficient; Bladder cancer; Diffusion-weighted image; Logistic regression algorithm; MRI

Year:  2020        PMID: 32318846     DOI: 10.1007/s00330-020-06796-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  11 in total

Review 1.  A primer on texture analysis in abdominal radiology.

Authors:  Natally Horvat; Joao Miranda; Maria El Homsi; Jacob J Peoples; Niamh M Long; Amber L Simpson; Richard K G Do
Journal:  Abdom Radiol (NY)       Date:  2021-11-26

2.  Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis.

Authors:  Bo Fan; Yuanbin Huang; Shuang Wen; Qiliang Teng; Xinrui Yang; Man Sun; Tingyu Chen; Yan Huang; Yumei Wang; Zhiyu Liu
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

3.  Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment.

Authors:  Yanfeng Zhao; Dehong Luo; Dan Bao; Zhou Liu; Yayuan Geng; Lin Li; Haijun Xu; Ya Zhang; Lei Hu; Xinming Zhao
Journal:  Cancer Imaging       Date:  2022-01-28       Impact factor: 3.909

4.  Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer.

Authors:  Zongtai Zheng; Zhuoran Gu; Feijia Xu; Niraj Maskey; Yanyan He; Yang Yan; Tianyuan Xu; Shenghua Liu; Xudong Yao
Journal:  Cancer Imaging       Date:  2021-12-04       Impact factor: 3.909

5.  PIxel-Level Segmentation of Bladder Tumors on MR Images Using a Random Forest Classifier.

Authors:  Ziqi Li; Na Feng; Huangsheng Pu; Qi Dong; Yan Liu; Yang Liu; Xiaopan Xu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer.

Authors:  Zongtai Zheng; Feijia Xu; Zhuoran Gu; Yang Yan; Tianyuan Xu; Shenghua Liu; Xudong Yao
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 7.  Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer.

Authors:  Xiaopan Xu; Huanjun Wang; Yan Guo; Xi Zhang; Baojuan Li; Peng Du; Yang Liu; Hongbing Lu
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

Review 8.  MRI as a Tool to Assess Interstitial Cystitis Associated Bladder and Brain Pathologies.

Authors:  Rheal A Towner; Nataliya Smith; Debra Saunders; Robert E Hurst
Journal:  Diagnostics (Basel)       Date:  2021-12-08

9.  A radiomics-based nomogram for preoperative T staging prediction of rectal cancer.

Authors:  Xue Lin; Sheng Zhao; Huijie Jiang; Fucang Jia; Guisheng Wang; Baochun He; Hao Jiang; Xiao Ma; Jinping Li; Zhongxing Shi
Journal:  Abdom Radiol (NY)       Date:  2021-06-03

10.  Deep Learning on Enhanced CT Images Can Predict the Muscular Invasiveness of Bladder Cancer.

Authors:  Gumuyang Zhang; Zhe Wu; Lili Xu; Xiaoxiao Zhang; Daming Zhang; Li Mao; Xiuli Li; Yu Xiao; Jun Guo; Zhigang Ji; Hao Sun; Zhengyu Jin
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.